ACADIA Pharmaceuticals Inc. (($ACAD)) announced an update on their ongoing clinical study. Study Overview: ACADIA Pharmaceuticals Inc. is ...

Monlunabant shows significant and clinically meaningful weight loss over 16 weeks in patients with obesity and metabolic ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...

Differential equations are fundamental tools in physics: they are used to describe phenomena ranging from fluid dynamics to general relativity. But when these equations become stiff (i.e. they involve ...

aDepartment of Surgery, University of California Irvine School of Medicine, Irvine, CA 92868, USA bDepartment of Medicine (Gastroenterology), University of California Irvine School of Medicine, Irvine ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...

You are free to share (copy and redistribute) this article in any medium or format within the parameters below: Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

Obesity has been historically a stubborn chronic metabolic disease, resistant to multiple therapeutic modalities. Although effective in the short-term for some people, lifestyle interventions have ...

We've all heard about the uncomfortable side effects that come with taking GLP-1 medications like Ozempic and Wegovy: upset stomach, constipation, nausea, hair loss... The list goes on. But ...

SEATTLE -- GLP-1 receptor agonist use was tied with a reduced risk for fracture among older women with type 2 diabetes, a retrospective cohort study found. Among over 350,000 GLP-1 users, there was a ...